Trending...
- Governor Gavin Newsom signs SB 27, strengthening California's CARE Act and expanding access to behavioral health services
- Mullins McLeod Surges Into SC Governor's Race with $1.4 Million Raised in First Quarter; Most from His Own Commitment, Not Political Pockets
- RNHA FL Unveils Bold New Leadership Ahead of 2026 Elections
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Verrica Pharmaceuticals Inc. ("Verrica" or "the Company") (NASDAQ: VRCA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company's securities between May 28, 2021 and May 24, 2022, inclusive (the ''Class Period''), are encouraged to contact the firm before August 5, 2022.
If you are a shareholder who suffered a loss, click here to participate.
More on The Californer
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. Verrica suffered from manufacturing problems at its contract manufacturer's facility during bulk production of its lead product candidate, VP-102. These deficiencies had not been successfully remediated when the Company resubmitted its NDA for VP-102 to the FDA. This failure was likely to impact the chances of regulatory approval for the Company's product candidate. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Verrica, investors suffered damages.
More on The Californer
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Contacts
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com
Investors who purchased the Company's securities between May 28, 2021 and May 24, 2022, inclusive (the ''Class Period''), are encouraged to contact the firm before August 5, 2022.
If you are a shareholder who suffered a loss, click here to participate.
More on The Californer
- New West Symphony: E.T. The Extra-Terrestrial in Concert
- Vesper Public Relations is selected as an official supplier of the LASEC Business Connect Program
- California announces coalition of Governors forming new alliance to protect public health from political interference
- $73.6M Pipeline, $10M Crypto Play & Legal Firepower: Why Investors Are Watching Cycurion (N A S D A Q: CYCU) Like a Hawk
- Grammy award winning Cuban-Canadian artist Alex Cuba releases its 11th studio album, "Indole"
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. Verrica suffered from manufacturing problems at its contract manufacturer's facility during bulk production of its lead product candidate, VP-102. These deficiencies had not been successfully remediated when the Company resubmitted its NDA for VP-102 to the FDA. This failure was likely to impact the chances of regulatory approval for the Company's product candidate. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Verrica, investors suffered damages.
More on The Californer
- Thread Advisory Group Launches to Help Retailers Turn Strategy Into Lasting Results
- QView Medical and Eve Wellness Announce Partnership to Advance Direct-to-Consumer Breast Cancer Screening With FDA-Approved AI
- New Article Reveals Common Pricing Pitfalls in Flooring Projects — And How to Avoid Them
- Inside the Practice of a Caring Dentist Bringing Personalized Care to La Jolla
- Airbus Defence and Space and Omnitronics Sign MoU to Advance Interoperability in Critical Communications
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Contacts
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com
Filed Under: Business
0 Comments
Latest on The Californer
- Aissist.io Launches Hybrid AI Workforce to Solve AI Pilot Failure for Customer Support Automation
- Milwaukee Job Corps Center: Essential Workforce Training—Admissions Now Open
- Christy Sports Makes Snowsports More Accessible for Families to Get Outside Together
- MainConcept Completes Management Buyout to Become Independent Company
- Zip launches modern, affordable software for small moving companies
- LIB Industry Expands Full-Series Salt Spray Corrosion Test Chambers to Meet Global Testing Standards
- The Easy Way to Collect Every Wedding Photo from Your Guests - No App Needed
- Rick Roco Ignites San Francisco's Pop Surrealism Scene
- Official City of Long Beach Statement Regarding Cease and Desist Notices for Unpermitted Event on October 11, 2025
- REPRESENTATION REVOLUTION: FLM TV Network Launches as America's First Truly Diverse Broadcast Network
- Hunger Action Los Angeles to Host 2025 Fundraising Gala on World Food Day at Guelaguetza Restaurant
- OhMyPretty Burmese Curly Bundles Redefine Long-Lasting, Chic, Versatile Curls
- New Book Call all Jews to Accept Jesus as the Messiah
- Flux AI Launches CRAISEE — The World's First All-in-One Generative AI Platform
- Governor Newsom pre-deploys additional storm safety resources to Southern California ahead of extreme weather
- 10xDev Launches in Los Angeles
- City of Long Beach Preparing for Upcoming Weather Event, Urges Residents to Take Precautions
- Jimmy Swinder Launches "Jimmy Swinder Productions," Expanding Creative Reach
- Industrial CNC Machinery automates machining processes with high accuracy and reduced labor costs
- For Nat'l. Novel Writing Month: Check out The Next Big Thing in Entertainment for Books, Movies & TV